Targeting the upstream transcriptional activator of PD-L1 as an alternative strategy in melanoma therapy.
Zhu B, Tang L, Chen S, Yin C, Peng S, Li X, Liu T, Liu W, Han C, Stawski L, Xu ZX, Zhou G, Chen X, Gao X, Goding CR, Xu N, Cui R, Cao P.
Zhu B, et al. Among authors: peng s.
Oncogene. 2018 Sep;37(36):4941-4954. doi: 10.1038/s41388-018-0314-0. Epub 2018 May 22.
Oncogene. 2018.
PMID: 29786078